Ligand Pharmaceuticals
North America, California, United States, San Diego
Description
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies.
Investor Profile
Ligand Pharmaceuticals has backed more than 10 startups, with 3 new investments in the last 12 months alone. The firm has led 7 rounds, about 70% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Corporate Round, Post Ipo Debt, Series C rounds (top funding stages).
- Majority of deals are located in United States, Austria.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Led 2 rounds in the past year.
Stage Focus
- Corporate Round (30%)
- Post Ipo Debt (20%)
- Series C (10%)
- Debt Financing (10%)
- Series A (10%)
- Post Ipo Equity (10%)
- Series Unknown (10%)
Country Focus
- United States (80%)
- Austria (20%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Life Science
- Hospital
- Medical Device
- Biopharma
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Ligand Pharmaceuticals frequently co-invest with?
What are some of recent deals done by Ligand Pharmaceuticals?
Find More Investors Like Ligand Pharmaceuticals
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
